Annual Reviews tagline graphic
  Hello. Sign in to get personalized recommendations. New user? Register now.
 
Home Order Browse Search Profile Help Contact Us
Abstract
Annual Review of Immunology
Vol. 21: 685-711 (Volume publication date April 2003)
(doi:10.1146/annurev.immunol.21.120601.141040)
TOLEROGENIC DENDRITIC CELLS*

Ralph M. Steinman1, Daniel Hawiger2, and Michel C. Nussenzweig2
1Laboratory of Cellular Physiology and Immunology The Rockefeller University, New York, New York 10021-6399; email:
2Laboratory of Molecular Immunology and Howard Hughes Medical Institute, Chris Browne Center for Immunology, The Rockefeller University, New York, New York 10021-6399;

Abstract Dendritic cells (DCs) have several functions in innate and adaptive immunity. In addition, there is increasing evidence that DCs in situ induce antigen-specific unresponsiveness or tolerance in central lymphoid organs and in the periphery. In the thymus DCs generate tolerance by deleting self-reactive T cells. In peripheral lymphoid organs DCs also induce tolerance to antigens captured by receptors that mediate efficient uptake of proteins and dying cells. Uptake by these receptors leads to the constitutive presentation of antigens on major histocompatibility complex (MHC) class I and II products. In the steady state the targeting of DC antigen capture receptors with low doses of antigens leads to deletion of the corresponding T cells and unresponsiveness to antigenic rechallenge with strong adjuvants. In contrast, if a stimulus for DC maturation is coadministered with the antigen, the mice develop immunity, including interferon-γ-secreting effector T cells and memory T cells. There is also new evidence that DCs can contribute to the expansion and differentiation of T cells that regulate or suppress other immune T cells. One possibility is that distinct developmental stages and subsets of DCs and T cells can account for the different pathways to peripheral tolerance, such as deletion or suppression. We suggest that several clinical situations, including autoimmunity and certain infectious diseases, can be influenced by the antigen-specific tolerogenic role of DCs.

Full TextPDF

Chain of Reviews: Annual Reviews chapters connected to this topic

Most recent citing papers (via CrossRef)

Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo
European Journal of Immunology:NA-NA (2009)
Phenotypic and functional markers for 1α,25-dihydroxyvitamin D 3 -modified regulatory dendritic cells
Clinical & Experimental Immunology 157(1):48-59 (2009)
Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis
Nephrology Dialysis Transplantation 24(7):2151-2156 (2009)
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment
International Immunology 21(7):779-791 (2009)
Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment
Blood 113(25):6277-6287 (2009)
 
Series Home > Table of Contents > Abstract

Prev. Article | Next Article
Full-text HTML
View/Print PDF (346.7 KB)
Add to Favorites
Email link to a friend

Add to CiteULike Add to Connotea Add to del.icio.us

 
 
Quick Search
for 
Authors:
Ralph M. Steinman
Daniel Hawiger
Michel C. Nussenzweig
Keywords:
tolerance
antigen processing
DEC-205

Users who read this review also read:

, , , , , , ,
Annual Review of Immunology. Volume 18, Page 767-811, Apr 2000
Abstract | Full Text | PDF (410 KB) | Add to Favorites | Related 
, , , ,
Annual Review of Immunology. Volume 20, Page 621-667, Apr 2002
Abstract | Full Text | PDF (333 KB) | Add to Favorites | Related 
, ,
Annual Review of Immunology. Volume 26, Page 293-316, Apr 2008
Abstract | Full Text | PDF (603 KB) | Add to Favorites | Related 
, , ,
Annual Review of Immunology. Volume 27, Page 485-517, Apr 2009
Abstract | Full Text | PDF (285 KB) | Add to Favorites | Related 

2009 Annual Reviews. All Rights Reserved.
  Technology Partner - Atypon Systems, Inc.